Insider · CIK 0001393945

Reynolds Thomas C

Reports to the SEC for 3 companies · BOTHELL, WA

sec.gov

Transactions

Companies

Filings

CIK

0001393945

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-15	LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2023-09-29	LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-07-05	LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+87.5K sh	—	—	87,500
2021-07-01	LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2020-07-02	LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2019-12-19	LITSLite Strategy, Inc.P Purchase	Director	PPurchase	+10K sh	$1.60	+$16K	10,000
2019-07-01	LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2018-07-12	LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2017-07-06	LITSLite Strategy, Inc. · Option to purchase shares of common stockA Award	Director	AAward	+40K sh	—	—	121,049
2016-07-29	LITSLite Strategy, Inc. · Option to purchase shares of common stockA Award	Director	AAward	+40K sh	—	—	81,049
2015-07-28	LITSLite Strategy, Inc. · Option to purchase shares of common stockA Award	Director	AAward	+20K sh	—	—	41,049
2014-07-14	LITSLite Strategy, Inc. · Option to purchase shares of common stockA Award	Director	AAward	+8,000 sh	—	—	21,049
2013-07-15	LITSLite Strategy, Inc. · Options to purchase shares of common stockA Award	Director	AAward	+6,730 sh	—	—	13,049
2013-02-07	LITSLite Strategy, Inc. · Options to purchase shares of common stockA Award	Director	AAward	+6,319 sh	—	—	6,319
2013-01-28	Seagen Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,027 sh	$12.16	+$12.5K	58,628
2013-01-28	Seagen Inc.S Sale	Chief Medical Officer	SSale	−1,027 sh	$30.19	−$31K	57,601
2013-01-28	Seagen Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,576 sh	$12.16	+$19.2K	59,177
2013-01-28	Seagen Inc.S Sale	Chief Medical Officer	SSale	−1,576 sh	$30.19	−$47.6K	57,601
2013-01-28	Seagen Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,604 sh	$12.00	+$31.2K	60,205
2013-01-28	Seagen Inc.S Sale	Chief Medical Officer	SSale	−2,604 sh	$30.19	−$78.6K	57,601
2013-01-28	Seagen Inc.Incentive Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,027 sh	—	—	7,196
2013-01-28	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,604 sh	—	—	41,147
2013-01-28	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,576 sh	—	—	11,035
2013-01-25	Seagen Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,083 sh	$15.46	+$32.2K	59,684
2013-01-25	Seagen Inc.S Sale	Chief Medical Officer	SSale	−2,083 sh	$29.84	−$62.2K	57,601
2013-01-25	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,083 sh	—	—	58,116
2013-01-15	Seagen Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,679 sh	$11.09	+$40.8K	61,280
2013-01-15	Seagen Inc.S Sale	Chief Medical Officer	SSale	−3,679 sh	$28.01	−$103K	57,601
2013-01-15	Seagen Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+35.5K sh	$11.09	+$394K	93,093
2013-01-15	Seagen Inc.S Sale	Chief Medical Officer	SSale	−35.5K sh	$28.00	−$994K	57,601
2013-01-15	Seagen Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+35.5K sh	$11.09	+$394K	93,094
2013-01-15	Seagen Inc.S Sale	Chief Medical Officer	SSale	−35.5K sh	$28.00	−$994K	57,601
2013-01-15	Seagen Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+33.6K sh	$12.16	+$409K	91,244
2013-01-15	Seagen Inc.S Sale	Chief Medical Officer	SSale	−33.6K sh	$28.01	−$942K	57,601
2013-01-15	Seagen Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+12.6K sh	$12.00	+$151K	70,206
2013-01-15	Seagen Inc.S Sale	Chief Medical Officer	SSale	−12.6K sh	$28.01	−$353K	57,601
2013-01-15	Seagen Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,167 sh	$15.46	+$64.4K	61,768
2013-01-15	Seagen Inc.S Sale	Chief Medical Officer	SSale	−4,167 sh	$28.01	−$117K	57,601
2013-01-15	Seagen Inc.Incentive Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,679 sh	—	—	0
2013-01-15	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−35.5K sh	—	—	35,493
2013-01-15	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−35.5K sh	—	—	0
2013-01-15	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−12.6K sh	—	—	43,751
2013-01-15	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−33.6K sh	—	—	12,611
2013-01-15	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,167 sh	—	—	60,199
2012-12-10	Seagen Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,250 sh	$10.29	+$12.9K	58,851
2012-12-10	Seagen Inc.S Sale	Chief Medical Officer	SSale	−1,250 sh	$25.75	−$32.2K	57,601
2012-12-10	Seagen Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+5,338 sh	$11.09	+$59.2K	62,939
2012-12-10	Seagen Inc.S Sale	Chief Medical Officer	SSale	−5,338 sh	$25.75	−$137K	57,601
2012-12-10	Seagen Inc.Incentive Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−5,338 sh	—	—	3,679
2012-12-10	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,250 sh	—	—	0

Recent filings

Accepted (ET)
Jul 174
Reynolds Thomas C0000929638-25-002638
SEC(opens sec.gov)
Oct 124
Reynolds Thomas C0000929638-23-002769
SEC(opens sec.gov)
Jul 74
Reynolds Thomas C0000899243-22-025700
SEC(opens sec.gov)
Jul 64
Reynolds Thomas C0001209191-21-045663
SEC(opens sec.gov)
Jul 74
Reynolds Thomas C0000899243-20-018616
SEC(opens sec.gov)
Dec 204
Reynolds Thomas C0001209191-19-061475
SEC(opens sec.gov)
Jul 34
Reynolds Thomas C0001209191-19-040980
SEC(opens sec.gov)
Jul 164
Reynolds Thomas C0001209191-18-042673
SEC(opens sec.gov)
Jul 104
MEI Pharma, Inc.0001209191-17-044531
SEC(opens sec.gov)
Aug 14
MEI Pharma, Inc.0001209191-16-134683
SEC(opens sec.gov)
Jul 294
MEI Pharma, Inc.0001209191-15-062870
SEC(opens sec.gov)
Jul 164
MEI Pharma, Inc.0001209191-14-047426
SEC(opens sec.gov)
Jul 174
MEI Pharma, Inc.0001209191-13-036931
SEC(opens sec.gov)
Feb 114
Reynolds Thomas C0001209191-13-007560
SEC(opens sec.gov)
Jan 294
Reynolds Thomas C0001203311-13-000008
SEC(opens sec.gov)

Companies

Address

21823 30TH DRIVE SE

BOTHELL, WA, 98021